Calcium chloride minimizes the hemodynamic effects of propofol in patients undergoing coronary artery bypass grafting

L Tritapepe1, P Voci, P Marino

  • 1Department of Anesthesia and Intensive Care, University of Rome La Sapienza, Azienda Ospedaliera S Giovanni e Addolorata, Italy.

Insights

Calcium chloride (CaCl2) administration during anesthesia induction mitigates propofol's negative cardiac effects in coronary artery bypass grafting patients. This intervention preserves hemodynamic stability, crucial for cardiac surgery outcomes.

Area of Science:

  • Cardiovascular Anesthesiology
  • Pharmacology
  • Cardiac Surgery

Background:

  • Propofol is a common anesthetic agent.
  • Anesthetic induction can negatively impact cardiac function, especially in patients with compromised cardiovascular systems.
  • Coronary artery bypass grafting (CABG) patients are particularly vulnerable to hemodynamic changes during surgery.

Purpose of the Study:

  • To evaluate the hemodynamic effects of propofol during anesthesia induction.
  • To determine if calcium chloride (CaCl2) can counteract propofol-induced negative cardiac effects.
  • To assess the safety and efficacy of this intervention in CABG patients.

Main Methods:

  • A prospective, randomized study was conducted with 58 patients undergoing elective CABG.
  • Patients received fentanyl, pancuronium, and propofol for anesthesia induction.
  • Group A received saline, while Group B received calcium chloride (CaCl2) concurrently with propofol.

Main Results:

  • Propofol significantly decreased heart rate, mean arterial pressure, stroke volume index, cardiac index, and cardiac output in the control group (Group A).
  • In contrast, patients receiving CaCl2 (Group B) exhibited negligible changes in these hemodynamic parameters.
  • Mean arterial pressure decreased significantly in both groups, but less so in the CaCl2 group.

Conclusions:

  • Simultaneous administration of calcium chloride (CaCl2) during propofol induction minimizes adverse effects on cardiac function.
  • This strategy is beneficial for maintaining hemodynamic stability in patients undergoing cardiac surgery.
  • CaCl2 can be a valuable adjunct to propofol anesthesia in CABG patients.
Abstract

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...